HSA prohibited and restricted TCM herbs in Singapore: what clinics and medical halls should know
Last updated:
Singapore’s Health Sciences Authority (HSA) publishes a list of ingredients that traditional medicines (TM) and health supplements (HS) must not contain, or may contain only with conditions such as a warning label. Several familiar Chinese herbs are on it. This guide pulls out the TCM-relevant entries from HSA’s October 2025 guideline so clinic owners and dispensary staff can check their stock and suppliers.
Key facts
- Guideline
- HSA GL-CHPB-1-012, Guidelines on Prohibited and Restricted Ingredients in HS and TM (October 2025)
- Always prohibited
- Aristolochia spp. — aristolochic acids are controlled under the Poisons Act
- Also prohibited in TM
- e.g. Aconitum carmichaeli & kusnezoffii, Bufo (toad venom), Strychnos nux-vomica, Croton tiglium, Corydalis yanhusuo
- Restricted in TM
- e.g. Asarum (root, free of aristolochic acids), Ephedra, Stephania tetrandra, He Shou Wu — with mandatory cautionary statements
- CPM heavy metals
- Arsenic 5 ppm, mercury 0.5 ppm, lead 10 ppm, cadmium 0.3 ppm (limits revised in 2019)
1. Who the HSA list applies to
The guideline is addressed to dealers (importers, manufacturers, wholesalers) and sellers of health supplements and traditional medicines, including Chinese Proprietary Medicines (CPM). It says these products must not contain substances under the Poisons Act, the Misuse of Drugs Act, the Health Products regulations or the ASEAN negative lists, ingredients from human parts, endangered species (unless permitted), or undeclared active ingredients. HSA stresses that Annex A is not exhaustive. If your clinic dispenses raw herbs or makes its own preparations, confirm with HSA how these controls apply to you — and never stock Aristolochia, whose aristolochic acids are controlled under the Poisons Act.
2. TCM herbs prohibited in traditional medicines
| Ingredient (HSA Annex A) | Common Chinese name | Status in TM |
|---|---|---|
| Aristolochia spp. | 马兜铃属(关木通、广防己、青木香、天仙藤等) | Prohibited |
| Aconitum carmichaeli, A. kusnezoffii, A. coreanum, A. napellus | 川乌 / 附子、草乌、关白附 | Prohibited |
| Bufo gargarizans, B. melanostictus (venom, secretion, whole body) | 蟾酥、蟾蜍 | Prohibited |
| Strychnos nux-vomica (seed, fruit) | 马钱子 | Prohibited |
| Croton tiglium | 巴豆 | Prohibited |
| Corydalis yanhusuo and other Corydalis spp. | 延胡索(元胡) | Prohibited |
| Artemisia annua | 青蒿 | Prohibited |
| Prunus armeniaca | 苦杏仁 | Prohibited |
| Datura stramonium | 曼陀罗 | Prohibited |
| Hyoscyamus niger | 天仙子 | Prohibited |
| Gelsemium elegans | 钩吻(断肠草) | Prohibited |
| Abrus precatorius (seed) | 相思子 | Prohibited |
| Papaver spp. | 罂粟(罂粟壳) | Prohibited |
| Senecio scandens and other Senecio spp. | 千里光 | Prohibited |
| Chelidonium majus | 白屈菜 | Prohibited |
3. TCM herbs restricted in traditional medicines (with conditions)
These ingredients may be used in TM only if the stated conditions are met — most commonly the cautionary statement “Not suitable for long term use. Seek medical advice if needed.” on the label.
| Ingredient | Common Chinese name | Condition in TM |
|---|---|---|
| Asarum heterotropoides (root) | 细辛 | Must be free of aristolochic acids; cautionary statement |
| Ephedra spp. | 麻黄 | Cautionary statement (prohibited in health supplements) |
| Stephania tetrandra (root) | 粉防己(汉防己) | Cautionary statement |
| Polygonum multiflorum | 何首乌 | Statement that it may cause liver problems |
| Fritillaria spp. | 贝母 | Cautionary statement |
| Magnolia officinalis | 厚朴 | Cautionary statement |
| Brucea javanica (fruit, seed) | 鸦胆子 | Cautionary statement |
| Dryobalanops spp. | 龙脑冰片 | For topical use only; cautionary statement |
| Senna / Cassia spp. | 番泻叶 | Sennoside warning statement |
| Red yeast rice (Monascus) | 红曲 | Lovastatin below 1%; warning statement |
| Ginkgo biloba | 银杏 | Cautionary statement |
4. Heavy metal limits for Chinese Proprietary Medicines
HSA revised its heavy metal limits for CPM and other complementary health products in 2019, aligning with ASEAN and WHO limits: arsenic 5 ppm, mercury 0.5 ppm, lead 10 ppm (down from 20 ppm) and cadmium 0.3 ppm (newly added); copper was removed from the list. HSA regularly recalls batches that exceed these limits, so clinics should buy CPM only from HSA-licensed dealers and keep batch numbers on record.
5. A practical checklist for your dispensary
- Compare your herb and granule master list against HSA Annex A at least once a year — the list is updated from time to time.
- Ask suppliers for certificates confirming Asarum products are free of aristolochic acids.
- Record batch numbers and expiry dates so you can act quickly on an HSA recall.
- Do not stock products containing endangered species (e.g. tiger bone, rhino horn, pangolin scales) without the required permits.
- Never promote a product to the public as treating a named disease — see the advertising rules guide.
See how myClinic tracks herb stock, batches and expiry alerts →
Frequently asked questions
Which Chinese herbs are banned in Singapore?
Aristolochia species (e.g. Guan Mu Tong, Guang Fang Ji, Qing Mu Xiang) are prohibited, as aristolochic acids are controlled under the Poisons Act. HSA’s October 2025 guideline also prohibits ingredients such as Aconitum carmichaeli and kusnezoffii, toad venom (Bufo), Strychnos nux-vomica, Croton tiglium and Corydalis yanhusuo in traditional medicines and health supplements.
Is Xi Xin (Asarum) allowed in Singapore?
Asarum heterotropoides root is prohibited in health supplements but allowed with restrictions in traditional medicines: the product must be free of aristolochic acids and carry the statement “Not suitable for long term use. Seek medical advice if needed.”
What are the heavy metal limits for CPM in Singapore?
Since HSA’s 2019 revision: arsenic 5 ppm, mercury 0.5 ppm, lead 10 ppm and cadmium 0.3 ppm.
myClinic is all-in-one TCM clinic software for Singapore — registration, prescribing, dispensing and billing in one system.
Related
Herbal granules & CPM inventory guide
Tracking concentrated granules by the gram, expiry alerts and HSA CPM compliance.
Read more →Singapore TCM regulatory & digitalisation overview
How MOH, TCMPB, HSA, PDPC and IRAS regulate TCM clinics, and what digitalisation requires.
Read more →TCM clinic advertising & website rules
HCSA Section 31A, TCMPB rules on testimonials and titles, and signboard limits.
Read more →